NCT00534261View on ClinicalTrials.gov

Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?

PHASE4CompletedINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

November 30, 1999

Study Completion Date

February 29, 2004

Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
DRUG

Interferon beta-1a

IM injection

Trial Locations (3)

4011

Coordinating Research Site, Esch-sur-Alzette

8340

Coordinating Research Site, Sijsele-Damme

Unknown

Coordinating Research Site, Glasgow

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT00534261 - Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? | Biotech Hunter | Biotech Hunter